Fig. 3

Immune scores and stromal scores are associated with clinical features in AML. a-b Kaplan–Meier curves of OS and DFS for patients with high vs. low immune scores. c-d Kaplan–Meier curves of OS and DFS for patients with high vs. low stromal scores. (e–f, i) Distribution of immune scores for age (under 60 yrs vs. over 60 yrs), gender (female vs. male) and cytogenetic risk classification (favorable, intermediate, and poor). (g-h, k) Distribution of stromal scores for age, gender and cytogenetic risk classification. j GSEA delineates biological pathways correlated with immune scores. Several enrichment results with significant associations between high- and low-immune scores groups are shown